Creatine and Restless Legs Syndrome
Creatine supplementation does not exacerbate Restless Legs Syndrome (RLS) and is not listed as a risk factor or exacerbating agent in current clinical guidelines.
Guideline Evidence on RLS Exacerbating Factors
The 2025 American Academy of Sleep Medicine (AASM) clinical practice guideline provides explicit guidance on managing exacerbating factors in RLS 1:
The first step in RLS management should be addressing known exacerbating factors, which include:
Creatine is notably absent from this comprehensive list of exacerbating factors 1
The AASM guideline does not mention creatine supplementation anywhere in its pathophysiology review, which emphasizes iron deficiency, dopamine dysfunction, and genetic factors as primary mechanisms 2
Why the Confusion May Exist
The concern about creatine and RLS likely stems from confusion with other conditions:
Compartment Syndrome vs. RLS
Research has shown that creatine supplementation can increase anterior compartment pressure in the lower leg 3, 4:
- Creatine increased compartment pressure at rest by 76% and post-exercise by up to 150% after 6 days of supplementation 3
- These pressure elevations persisted after 34 days of supplementation 3, 4
However, compartment syndrome is clinically distinct from RLS 2:
- RLS shows circadian worsening (evening/night), while compartment syndrome does not 2
- RLS symptoms are relieved by movement, whereas compartment syndrome pain worsens with activity 2
- Compartment syndrome presents with sensory loss on examination, which is not characteristic of RLS 2
- RLS has an urge to move the limbs, while compartment syndrome causes pain and tightness 2
Clinical Bottom Line
There is no evidence-based reason to avoid or discontinue creatine supplementation in patients with RLS 1, 2. The supplement does not appear in any guideline as a causative or exacerbating factor for RLS.
Common Pitfall to Avoid
Do not confuse exercise-induced compartment syndrome (which creatine may worsen) with RLS symptoms 3, 4. These are separate clinical entities with different presentations, mechanisms, and management strategies 2.
If a patient taking creatine develops leg symptoms, distinguish between: